Home / Systemic hormones / Hydrocortisone
ATC H02AB09 · Glucocorticoids · updated 4 Nov 2026
Hydrocortisone shortage
As of 4 Nov 2026, Hydrocortisone has a reported shortage in 4 of the 16 countries we track (Canada, Germany, France, Switzerland), covering 9 products from 4 companies.
Is there a Hydrocortisone shortage?
Yes. As of 4 Nov 2026, Hydrocortisone is reported short in 4 of the 16 countries we track: Canada, Germany, France, Switzerland. The earliest expected return is 31 Dec 2026 (Germany). 8 of 9 affected products have no return date. New since 5 Oct 2026: France.
How the shortage spread
All cross-border shortagesCountries in the order the shortage started there (earliest start date of a product still short). First reported in Canada on 29 Feb 2016; most recently in Switzerland on 27 Jul 2026.
- CACanadasince 29 Feb 2016
- DEGermanysince 1 Jul 2019
- FRFrancesince 29 Feb 2024
- CHSwitzerlandsince 27 Jul 2026
Not on the official list in: United States, Italy, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, Japan, New Zealand, Australia.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Teva TEVA · NYSE / TASE, Viatris VTRS · Nasdaq, Takeda 4502 / TAK · Tokyo / NYSE
Compared with similar medicines
ATC group H02AB · GlucocorticoidsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION (10) | TEVA CANADA LIMITED | 29 Feb 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION (10) | TEVA CANADA LIMITED | 29 Feb 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION (10) | TEVA CANADA LIMITED | 29 Feb 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| DE | Hydrocortison PANPHARMA 100 mg | PANPHARMA GmbH | 1 Jul 2019 | 31 Dec 2026 | Other GMP Mängel |
| FR | Colofoam, mousse rectale | 29 Feb 2024 | not given | Not stated | |
| FR | Hydrocortisone Substipharm 100 mg, lyophilisat (flacon) et solution pour usage parentéral discontinuation | 30 Jun 2026 | not given | Not stated | |
| FR | Hydrocortisone Upjohn 100 mg, préparation injectable limited | Viatris | 7 Oct 2026 | not given | Not stated |
| CH | PLENADREN Ret Tabl 5 mg Ds 50 Stk | Takeda Pharma AG | 27 Jul 2026 | not given | Not stated |
| CH | PLENADREN Ret Tabl 20 mg Ds 50 Stk | Takeda Pharma AG | 7 Aug 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Hydrocortisone shortage?
Yes. As of 4 Nov 2026, Hydrocortisone is reported short in 4 of the 16 countries we track: Canada, Germany, France, Switzerland. The earliest expected return is 31 Dec 2026 (Germany). 8 of 9 affected products have no return date. New since 5 Oct 2026: France.
When will Hydrocortisone be back in stock?
Companies expect supply back from 31 Dec 2026 in Germany; Canada: no date given; Germany: 31 Dec 2026; France: no date given; Switzerland: no date given. These are company estimates reported to each authority.
Why is Hydrocortisone in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Hydrocortisone shortages?
Teva, Takeda, Panpharma, Viatris.